Renata Limited

Renata Limited
Company typeLimited Company
DSE: RENATA
IndustryPharmaceutical
Founded1993; 32 years ago (1993)
Headquarters
Mirpur, Dhaka
,
Bangladesh
Area served
South Asia, South East Asia, Africa, Europe and Latin America
Key people
Syed S Kaiser Kabir (CEO)
ProductsMaxpro, Rolac, Fenadin, Rolip, Furoclav and more
Number of employees
3485
Websiterenata-ltd.com

Renata Limited (formerly Pfizer Laboratories (Bangladesh) Limited), also known as Renata, is one of the top ten pharmaceutical manufacturers in Bangladesh in terms of revenue.[1] Renata is engaged in the manufacture and marketing of human pharmaceutical and animal health products.[2] The company also manufactures animal therapeutics and nutrition products. As of 2024, Renata employs about 11,000 people in its head office in Mirpur, Dhaka[3] and its 14 production facilities in Mirpur, Dhaka, Rajendrapur, Gazipur and Bhaluka, Mymensingh.[4]

Financial data

Renata is a publicly traded company on the Dhaka Stock Exchange (ticker: RENATA).[5]

Production facilities

Recently, Renata Limited has received the UK MHRA approval for its Potent Product Facility.[6] This facility is exporting prednisolone to the UK.[7]

The company also operates four other manufacturing units – the original Pfizer facility for general products, a UNICEF-approved SFF (Sachet Filling Facility).[8]

Partnerships

Recently, GAIN (The Global Alliance for Improved Nutrition) provided US$2.9 million to Renata Limited and BRAC, one of the biggest NGOs in the developing world, to build and operate an innovative business model to produce and deliver multi-nutrient powders to vulnerable infants in Bangladesh.[9]

Controversy

Renata was fined on 21 January 2016 by the Department of Environment for damaging the environment. The company has also illegally occupied land owned by the forest department.[10] Syed S. Kaiser Kabir, the CEO, of the company had illegally grabbed government land to build a house near Dhaka-Mymensingh highway.[11]

References

  1. ^ Haroon, Jasim Uddin (15 February 2010). "Square tops list of 10, Incepta second". The Financial Express. Dhaka. Archived from the original on 1 October 2011.
  2. ^ "Renata Limited". Datamonitor. Archived from the original on 2011-07-28.
  3. ^ "Renata Ltd". Wall Street Journal. Retrieved 9 September 2024.
  4. ^ "Renata starts directly exporting medicines to US". The Daily Star. 4 April 2024.
  5. ^ "Renata Ltd (RENATA:Dhaka)". Bloomberg Businessweek. Archived from the original on 5 October 2012.
  6. ^ Chowdhury, Raihan M. (10 November 2007). "Pharmaceutical sector development necessitates vertical integration". The Financial Express. Dhaka.
  7. ^ Khan, Jasim Uddin (4 June 2008). "Renata set to export medicine to Europe". The Daily Star.
  8. ^ "Participants". Global Alliance for Improved Nutrition. Archived from the original on 2009-05-31.
  9. ^ "GAIN's effectiveness in reducing malnutrition confirmed in its new Annual Report". Global Alliance for Improved Nutrition. Archived from the original on 2010-08-21.
  10. ^ অপকর্মে বেপরোয়া রেনাটা. Kaler Kantho (in Bengali). Retrieved 2018-01-10.
  11. ^ অপকর্মে বেপরোয়া রেনাটা. Bangladesh Pratidin (in Bengali). Retrieved 2018-01-10.